Targeting therapy in pemphigus: Where are we now and where are we going?

Pemphigus is a heterogeneous group of autoimmune skin disorders characterized by blistering of the skin and mucosal membranes, potentially affecting the quality of life if left unchecked. The current mainstay of treatment is systemic corticosteroids and immunosuppressive agents. Nevertheless, long-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Abulikemu, Kailibinuer, Hu, Fengxia, Liang, Junqin, Kang, Xiaojing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245244/
https://www.ncbi.nlm.nih.gov/pubmed/37292301
http://dx.doi.org/10.1016/j.heliyon.2023.e16679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245244/
https://www.ncbi.nlm.nih.gov/pubmed/37292301
http://dx.doi.org/10.1016/j.heliyon.2023.e16679

Ejemplares similares